Matthias Guckenberger
Zurich radiation oncologist and ESTRO Past-President, a leading voice on stereotactic radiotherapy for oligometastases.
Overview
Matthias Guckenberger is Past-President of ESTRO and serves on its board; he is a radiation oncologist at University Hospital Zurich. His research focuses on stereotactic body radiotherapy, the characterisation and treatment of oligometastatic disease, and radiotherapy for lung cancer. He has led European consensus work defining oligometastatic disease and its treatment.
Pages like this
not linked directly; found by shared links- PersonBarbara Jereczek-Fossa
Shares European Society for Radiotherapy and Oncology and the tags leadership, clinician-scientist, radiotherapy.
- PersonHidetoshi Hayashi
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonMartin Schuler
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonCaicun Zhou
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonKaren Kelly
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonWen-Zhao Zhong
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonJin Seok Ahn
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonTony S. K. Mok
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.